Skip to main navigation
Skip to search
Skip to main content
Open Universiteit research portal Home
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Circulating tumor DNA and their added value in molecular oncology.
MPG Leers
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Circulating tumor DNA and their added value in molecular oncology.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Circulating Tumor DNA (ctDNA)
100%
Molecular Oncology
100%
Blood Samples
40%
Peripheral Blood
40%
Solid Tumors
40%
Liquid Biopsy
40%
Tissue Sampling
20%
Clinical Practice
20%
Oncology
20%
Clinical Application
20%
Cancer Patients
20%
Personalized Medicine
20%
Circulating Tumor Cells
20%
Clinical Implementation
20%
Verge
20%
Targeted Therapy
20%
Cell-free DNA (cfDNA)
20%
Molecular Diagnostics
20%
Non-small Cell Lung Cancer (NSCLC)
20%
Primary Tumor
20%
Hematological Malignancies
20%
Medicine Therapy
20%
Treatment Choice
20%
Metastatic Deposit
20%
Tumor Malignancy
20%
Gene mutation
20%
Multidrug-resistant
20%
Preanalytical Factors
20%
DNA Molecule
20%
Therapeutic Agents
20%
Biological Characteristics
20%
Tumor Deposits
20%
Therapeutic Target
20%
New Discovery
20%
Medicine and Dentistry
Circulating Tumor DNA
100%
Molecular Oncology
100%
Solid Malignant Neoplasm
40%
Liquid Biopsy
40%
Oncology
20%
Malignant Neoplasm
20%
Personalized Medicine
20%
Circulating Tumor Cell
20%
Cell-Free DNA
20%
Molecular Diagnosis
20%
Non Small Cell Lung Cancer
20%
Primary Tumor
20%
Targeted Therapy
20%
Tissue Sampling
20%
Gene Mutation
20%
Hematologic Malignancy
20%